Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials.
Chesney
M A
MA
Center for AIDS Prevention Studies, School of Medicine, University of California, San Francisco, USA.
Lurie
P
P
Coates
T J
TJ
D016915:AIDS Vaccines; D002986:Clinical Trials as Topic / Q000523:psychology / Q000592:standards*; D017326:Clinical Trials, Phase III as Topic / Q000523:psychology / Q000592:standards; D015331:Cohort Studies; D003376:Counseling; D004311:Double-Blind Method; D015658:HIV Infections / Q000517:prevention & control* / Q000523:psychology; D015438:Health Behavior; D006801:Humans; D007258:Informed Consent; D008297:Male; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012307:Risk Factors; D014838:Volunteers / Q000523:psychology
D016915:AIDS Vaccines